The Patent Finder

Terms ending in 2027

Ablynx N.V.

Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,028,816Polypeptides and Polypeptide Constructs Comprising Single Domain Antibodies Directed Against Von Willebrand Factor
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 10,618,966Methods for the Treatment of INTERLEUKIN-6 Receptor-Related Diseases and Disorders
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 7,939,277Methods and Assays for Distinguishing Between Different Forms of Diseases and Disorders Characterized by Thrombocytopenia And/Or by Spontaneous Interaction Between Von Willebrand Factor (VWF) and Platelets
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 9,617,341Methods for Blocking or Reducing Binding of INTERLEUKIN-6 to INTERLEUKIN-6 Receptor
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 9,611,326INTERLEUKIN-6 Receptor Binding Polypeptides
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 9,605,072Nucleic Acids That Encode INTERLEUKIN-6 Receptor Binding Polypeptides
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 10,844,123Amino Acid Sequences That Modulate the Interaction Between Cells of the Immune System
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 9,512,236Amino Acid Sequences Directed Against Gpcrs and Polypeptides Comprising the Same for the Treatment of Gpcr-Related Diseases and Disorders
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited